Stay updated on CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Sign up to get notified when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.
Latest website image capture
Clouds background image

Latest updates to the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-11-03T23:52:54.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates. The page continues to display a 403 error, and its revision label advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:56:20.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.0 to v3.7.1, while the page remained a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:09:49.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study page displays a 403 Forbidden error instead of the study record content, replacing the expected information with an error screen and navigation footer.
    Difference
    21%
    Check dated 2026-09-23T00:00:13.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A prompt to locate contact information was added to the page, improving accessibility for inquiries about the study. The page revision was updated to v3.7.0, reflecting an updated version of the content.
    Difference
    0.1%
    Check dated 2026-09-16T00:02:00.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.6.6, replacing v3.6.5, indicating a maintenance release of the site. It reflects an update to the site's version tag rather than any changes to study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-01T19:33:53.000Z thumbnail image

Stay in the know with updates to CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Enter your email address, and we'll notify you when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.